At least a dozen companes involved in the microarray and biochip industry will be among the 1,110 exhibitors at the giant biannual Analytica tradeshow scheduled for May 11-14 in Munich.

From NimbleGen Systems of Madison, Wisc., to glassmakers Schott Nexterion and Corning, as well as platform providers like Agilent Technologies and Applied Biosystems, a broad list of companies make this tradeshow for analysis and the life sciences, laboratory automation, and data and process management the highlight of a second calendar quarter of 2004.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.